3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
42
Colonic Neoplasms
14
Rectal Neoplasms
13
Neoplasms
12
Neoplasm Metastasis
12
Head and Neck Neoplasms
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Carcinoma, Squamous Cell
4
Breast Neoplasms
4
Recurrence
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Gastrointestinal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma
2
Biliary Tract Neoplasms
2
Urinary Bladder Neoplasms
1
Solid Tumors
1
Ovarian Neoplasms
1
Inflammatory Breast Neoplasms
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Exanthema
1
Interventions
Sunitinib
64
Nivolumab
42
pembrolizumab
36
Bevacizumab
32
Everolimus
31
Sorafenib
25
pazopanib
23
Axitinib
23
cabozantinib
14
aldesleukin
13
Ipilimumab
13
temsirolimus
11
Interferon alpha-2
11
Cyclophosphamide
10
avelumab
9
Magnetic Resonance Spectroscopy
9
Interleukin-2
9
lenvatinib
8
atezolizumab
8
Radiosurgery
8
Gemcitabine
8
Immunoglobulin G
7
Erlotinib Hydrochloride
7
Disulfides
6
fludarabine phosphate
5
Radiotherapy
5
Fluorodeoxyglucose F18
5
peginterferon alfa-2b
4
Vorinostat
4
Tyrosine Kinase Inhibitors
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Renal Cell
×
Panitumumab
×
Clear all
No trials found.